SV

Street Verdict

Analyst Scorecard

A record of what Samit Vartak said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on the pharma space, noting that it is looking good after a market correction. He expects companies in this sector to achieve 15-18% earnings growth, potentially doubling profits in three to three-and-a-half years and stock prices in three to five years.”
Nifty PharmaBullishCalled 18 Feb 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Samit Vartak’s full track record